Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Reduction in Tamoxifen Metabolites Endoxifen and...
Journal article

Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction

Abstract

BACKGROUND: Cannabidiol (CBD) serves as a promising medicine, with few known adverse effects apart from the potential of drug interactions with the cytochrome P450 system. It has been hypothesized drug interactions may occur with chemotherapeutic agents, but no supporting evidence has been published to date. CASE: A 58-year-old female with a history of bilateral breast carcinoma in remission, was treated with tamoxifen for breast cancer …

Authors

Parihar V; Rogers A; Blain AM; Zacharias SRK; Patterson LL; Siyam MA-M

Journal

Journal of Pharmacy Practice, Vol. 35, No. 2, pp. 322–326

Publisher

SAGE Publications

Publication Date

April 2022

DOI

10.1177/0897190020972208

ISSN

0897-1900